CUSIX
Price
$15.67
Change
+$0.02 (+0.13%)
Updated
Aug 21 closing price
Net Assets
10.01M
VISVX
Price
$59.75
Change
+$0.43 (+0.72%)
Updated
Aug 21 closing price
Net Assets
68.3B
Interact to see
Advertisement

CUSIX vs VISVX

CUSIX vs VISVX Comparison Chart in %
View a ticker or compare two or three
VS
CUSIX vs. VISVX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CUSIX is a Hold and VISVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 68.3B vs. CUSIX (10M). VISVX pays higher dividends than CUSIX: VISVX (1.65) vs CUSIX (1.28). CUSIX was incepted earlier than VISVX: CUSIX (17 years) vs VISVX (28 years). CUSIX (4.22) is less costly to investors than VISVX (0.19). CUSIX is a more actively managed with annual turnover of: 38.00 vs. VISVX (25.00). VISVX has a lower initial minimum investment than CUSIX: VISVX (0) vs CUSIX (1000000). VISVX annual gain was more profitable for investors over the last year : 23.48 vs. CUSIX (13.15). VISVX return over 5 years is better than : 50.65 vs. CUSIX (7.20).
CUSIXVISVXCUSIX / VISVX
Total Expense Ratio1.000.19526%
Annual Report Gross Expense Ratio4.220.192,221%
Fund Existence17 years28 years-
Gain YTD13.72517.88177%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets10M68.3B0%
Annual Yield % from dividends1.281.6578%
Returns for 1 year13.1523.4856%
Returns for 3 years27.6054.6850%
Returns for 5 years7.2050.6514%
Returns for 10 years34.34133.2626%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX23.980.24
+1.01%
Saratoga Health & Biotechnology A
GQJIX12.860.08
+0.63%
GQG Partners Intl Qual Val Fd Ins
DMCFX32.440.17
+0.53%
Invesco Discovery Mid Cap Growth R5
GRMIX34.660.15
+0.43%
Nationwide S&P 500 Index R6
TNXIX23.190.09
+0.41%
1290 Avantis U.S. Large Cap Growth I